Comparison of the effects of desloratadine 5‐mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Nasal congestion is a chronic symptom of seasonal allergic rhinitis (SAR) that is often difficult to treat with antihistamines. Desloratadine, a new, potent, H 1‐receptor antagonist has been shown to decrease nasal congestion in clinical trials and to maintain nasal airflow in response to grass pollen exposure. We compared the effects of desloratadine 5 mg and placebo on nasal airflow, nasal secretion weights and SAR symptoms, including nasal congestion, in patients exposed to grass pollen in an environmental exposure unit. Methods: Forty‐six grass pollen allergic SAR patients received desloratadine or placebo for 7 days, followed by a 10‐day washout, and then crossed over to the other treatment for 7 days. A 6‐h allergen exposure was performed at the end of each treatment period. Results: Desloratadine was significantly superior to placebo in maintaining nasal airflow (P≤ 0.014) and lessening the increase in nasal secretion weights (P < 0.001) throughout allergen exposure. SAR symptom scores, including nasal congestion, were significantly less with desloratadine than placebo (P≤ 0.001). Desloratadine was well tolerated. Conclusions: This study confirms that, compared with placebo, desloratadine can maintain nasal airflow and reduce nasal secretion weights and the severity of SAR symptoms, including nasal congestion, in SAR patients exposed to grass pollen allergen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Weiner, J. M., Abramson, M. J., & Puy, R. M. (1998) · BMJ · doi:10.1136/bmj.317.7173.1624 · Cited by 527 · cited 1×
“Nasally inhaled corticosteroids are an effective treatment for allergic symptoms in SAR (7) and down-regulate the allergic inflammatory response at the molecular level (8).”
BackgroundWang, D., Clement, P., & Smitz, J. (1996) · Acta Oto-Laryngologica · doi:10.3109/00016489609137720 · Cited by 32 · cited 1×
“The pathogenesis of nasal obstruction is complex and many allergic mediators are involved, including eicosanoids (2, 3), histamine (4), neuropeptides (5), and cytokines, such as interleukin-4 (IL-4) (6).”
Background
Cited by
Horak, F., Zieglmayer, P., Zieglmayer, R., Lemell, P., Devillier, P., Montagut, A., Mélac, M., Galvain, S., Jean-Alphonse, S., Van Overtvelt, L., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.06.006 · Cited by 175
Self-citationSecond-Generation Antihistamines: Actions and Efficacy in the Management of Allergic Disorders
Golightly, L. K., & Greos, L. S. (2005) · Drugs · doi:10.2165/00003495-200565030-00004 · Cited by 111
Rösner-Friese, K., Kaul, S., Vieths, S., & Pfaar, O. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.045 · Cited by 66
Bousquet, J., Bindslev‐Jensen, C., Canonica, G. W., Fokkens, W., Kim, H., Kowalski, M., Magnan, A., Mullol, J., & Van Cauwenberge, P. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00577.x · Cited by 56
The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis
Bareille, P., Murdoch, R. D., Denyer, J., Bentley, J., Smart, K., Yarnall, K., Zieglmayer, P., Zieglmayer, R., Lemell, P., & Horak, F. (2013) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201890 · Cited by 41
Self-citation
Metadata
- Authors
- Horak, F., Stübner, P., Zieglmeyer, R., & Harris, A. G.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2003-05-21
- Volume
- 58
- Issue
- 6
- Pages
- 481-485
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2011147287
- Cited by
- 54
- References
- 3
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of the effects of desloratadine 5‐mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. https://app.cochat.ai/papers/10.1034/j.1398-9995.2003.00148.x
- The paper
- Horak, F., Stübner, P., Zieglmeyer, R., & Harris, A. G. (2003). Comparison of the effects of desloratadine 5‐mg daily and placebo on nasal airflow and seasonal allergic rhinitis symptoms induced by grass pollen exposure. Allergy. https://doi.org/10.1034/j.1398-9995.2003.00148.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.